References
- Chou F. T., Khan A. H., Driscoll J. S. Potential nervous system antitumor agents. Aziridinylbenzoquinones. Journal of Medicinal Chemistry 1976; 19: 1302–1308
- Chou J., Chou T. C. Dose-effect analysis with microcomputers. Elsevier Science Publishers, Amsterdam 1985; 1–105
- Egorin M., Fox B., Speigel J., Gutierrez P., Friedman R., Bachur N. Cellular pharmacology in murine and human leukemic cell lines of diaziquone (NSC 182986). Cancer Research 1985; 45: 992–999
- Gutierrez P. L., Friedman R. D., Bachur N. R. Biochemical activation of AZQ (3,6-Diaziridinyl-2, 5-bis (carboethoxyamino)-1,4-benzoquinone) to its free radical species. Cancer Treatment Reports 1982; 66: 339–342
- Gutierrez P. L., Fox B., Mossoba M., Bachur N. Free radicals in quinone-containing antitumor agents: Electrochemical reduction of diaziquone (2,5-diaziridinyl-3,6-bis(carboethozyamino)-1,4-benzoquinone) and two analogs. Molecular Pharmacology 1984; 26: 582–586
- Gutierrez P. L., Egorin M. J., Fox B. M., Friedman R., Bachur N. R. Cellular activation of diaziquone (3,6-Dizairidinyl-2, 5-bis)carboethoxyamino)-1,4-benzoquinone to its free radical species. Biochemical Pharmacology 1985; 34: 1449–1455
- Gutierrez P. L., Biswal S., Nardino R., Biswal N. Reductive activation of diaziquone and possible involvement of free radicals and the hydroquinone/dianion. Cancer Research 1986; 46: 5779–5785
- James B. D., Wallbridge G. H. Metal tetrahydroborates. Progress in Inorganic Chemistry 1970; 11: 99–231
- Khan A., Driscoll J. Potential central nervous system antitumor agents: Aziridinylbenzoquinones. Journal of Medicinal Chemistry 1975; 19: 313–317
- King C. L., Wong S., Loo T. L. Alkylation of DNA by the new anticancer agent 3,6-diaziridinyl-2,5-bis(carboethoxyamino)-1,4-benzoquinone (AZQ). European Journal of Cancer and Clinical Oncology 1984; 20: 261–264
- Lyons J., Watson W. Preparation of diphenyl picrylhadrazyl. Journal of Polymer Science 1955; 18: 141–143
- Miner D., Kissinger P. Evidence for the involvement of N-acetyl-P-quinoneimine in acetaminophen metabolism. Biochemical Pharmacology 1979; 28: 3285–3290
- Mossoba M., Alizadeh M., Gutierrez P. Mechanism for the reductive activation of diaziquone. Journal of Pharmaceutical Science 1985; 74: 1249–1254
- Poochikian G., Kelly J. 2,5-Diaziridinyl-3,6-bis(carboethoxyamino)-1,4-benzoquinone II: Isolation and characterization of degradation products. Journal of Pharmaceutical Science 1981; 70: 162–167
- Szmigiero L., Kohn K. W. Mechanisms of DNA strand breakage and interstrand cross-linking by diaziridinylbenzoquinone (diaziquone) in isolated nuceli from human cells. Cancer Research 1984; 44: 4453–4457